Licenses · Combined Updated November 17, 2026
Dual-use privileges (pharmaceutical processor and cannabis dispensing facility)
The conversion path that lets Virginia's five existing medical cannabis operators also grow, process and sell to adults 21+, for a one-time $10 million fee.
| Fee | Amount | Status |
|---|---|---|
| One-time dual-use conversion fee (by May 1, 2027, or Board-approved installments over up to 3 years) | $10,000,000 | Set by law · source |
| Pharmaceutical processor permit: application | $10,000 | Draft rule · source |
| Pharmaceutical processor permit: initial | $120,000 | Draft rule · source |
| Pharmaceutical processor permit: annual renewal | $100,000 | Draft rule · source |
| Additional cultivation location: application / initial / annual renewal | $5,000 / $80,000 / $64,000 | Draft rule · source |
| Cannabis dispensing facility permit: application / initial / annual renewal (each site) | $4,000 / $40,000 / $30,000 | Draft rule · source |
| Reinspection (processor or dispensing facility) | $5,000 | Draft rule · source |
| Product registration (per product) | $50 | Draft rule · source |
| Change fees (name, PIC or ownership / background-check ownership change / inspection-triggering change) | $200 / $500 / $5,000 | Draft rule · source |
| Installment plan terms for the $10 million fee | Not yet set | Not yet published · source |
Dual-use privileges are not a license anyone can apply for. They are the bridge that lets Virginia’s existing medical cannabis companies, the pharmaceutical processors and their cannabis dispensing facilities, serve the adult-use market alongside patients. Because these operators already have grows, labs, stores and staff, they are expected to supply much of the market on July 1, 2027. If you are not one of the five, this page still matters: it explains your largest competitors, the impact accelerator they must fund, and where new storefronts will not come from.
Who holds it
Virginia allows one pharmaceutical processor permit per health service area (HSA), five in total (set by law, § 4.1-1602 B). The CCA lists them as (CCA processor list):
| HSA | Region | Permit holder (brand) |
|---|---|---|
| 1 | Northwestern | AYR Virginia |
| 2 | Northern | Jushi Holdings (“Beyond Hello”) |
| 3 | Southwest | Green Thumb Industries (“Rise”) |
| 4 | South Central | AYR Virginia (“Ayr”) |
| 5 | Eastern | Verano (“Zen Leaf”) |
One company holds two HSAs. That is allowed because the law grandfathers anyone who owned processor permits in more than one HSA on July 1, 2026, so long as they keep them (set by law, § 4.1-807 C).
What dual-use privileges let you do
Once the Board verifies a processor for dual use (set by law, § 4.1-1602.1 C):
- the pharmaceutical processor holds the privileges of, and must follow the rules for, a cultivation facility, a processing facility and a retail marijuana store;
- each cannabis dispensing facility holds the privileges of a retail marijuana store.
Limits that stay in place:
- Before July 1, 2027, processors may sell only to registered patients, their agents, and parents or guardians (set by law, enactment 17).
- Canopy: a processor must grow indoors only (a secure greenhouse counts) with no more than 70,000 sq ft of canopy in total across all its cultivation (set by law, § 4.1-1602 J). Across five processors that is up to 350,000 sq ft. The CCA’s capacity study stresses that this capacity serves medical and adult-use demand, so it is not 350,000 sq ft of new adult-use supply (recommended in CCA capacity study).
- Sites: up to five dispensing facilities per processor in its own HSA, plus one additional cultivation location if authorized (set by law, § 4.1-1602 B, J). The capacity study counts up to six storefronts per processor, 30 statewide, against 24 medical dispensing locations open today (CCA capacity study).
- Patients first: at least 35 hours a week open to patients (proposed in draft rules, Sept 2026, 3VAC10-40-25 D). Only pharmacists dispense to patients, with pharmacy technicians assisting (3VAC10-30-90; 3VAC10-40-25 A). A pharmacist-in-charge supervises the dispensing area (§ 4.1-1602 F).
- Drive-throughs: medical only, for pre-orders. Adult-use sales may not use a drive-through, curbside pickup or vending machine (proposed in draft rules, Sept 2026, 3VAC10-40-30 J, K; set by law, § 4.1-802 B 2).
- No other licenses. A person with an interest in a processor permit may hold no other marijuana establishment license except its own dispensing facility permits (set by law, §§ 4.1-807 B, 4.1-1602.1 E).
Location and size advantages
Two statutory carve-outs favor converting operators (set by law, § 4.1-1602.1 D):
- Processors and dispensing facilities operating on Dec. 1, 2026 are exempt from the § 4.1-810 B 3 location rules, including the 1,000-foot buffer from schools, hospitals, colleges and child day programs.
- Their retail floor space may exceed 2,500 sq ft if the premises was approved before Jan. 1, 2026, but the Board may not approve later changes that enlarge it.
New stand-alone stores face the 1,000-foot buffer and a possible 2,500 sq ft cap. Dispensing sites opened after Dec. 1, 2026 do not get the location exemption. They must also meet the draft’s 1,000-foot school and daycare rule (proposed in draft rules, Sept 2026, 3VAC10-30-140 B 1).
Fees
Set by law: a one-time $10 million conversion fee, paid in full by May 1, 2027 or through a Board-approved installment plan of no more than three years entered by May 1, 2027 (enactment 13).
Proposed in draft rules, Sept 2026 (3VAC10-20-30, -40):
| Permit | Application | Initial | Annual renewal | Reinspection |
|---|---|---|---|---|
| Pharmaceutical processor | $10,000 | $120,000 | $100,000 | $5,000 |
| Additional cultivation location | $5,000 | $80,000 | $64,000 | — |
| Cannabis dispensing facility (each) | $4,000 | $40,000 | $30,000 | $5,000 |
Product registration is $50 per product. Change fees are $200 (name, PIC, responsible party, minor ownership), $500 (ownership change needing a background check) and $5,000 (acquisition, expansion, remodel or relocation needing inspection) (proposed in draft rules, 3VAC10-20-15, -30).
Our math (estimate): a processor with a primary site, one added cultivation location and five dispensing facilities would pay about $314,000 a year in renewals under the draft ($100,000 + $64,000 + 5 × $30,000), on top of the $10 million conversion fee. For comparison, the largest stand-alone grow license (Tier V) renews at $45,000 under the draft.
Where the money goes: from May 1, 2027 to May 1, 2028, 75% of marijuana establishment annual license fees go to the Cannabis Equity Business Loan Fund (set by law, enactment 21). Whether the $10 million conversion fee counts as an “annual license fee” for that purpose is not stated; treat it as unconfirmed.
Conditions for verification
The Board must create a streamlined application by Feb. 1, 2027 (set by law, enactment 13). To be verified, a processor must:
- Apply in the manner and by the date the Board sets. The law says each processor “shall apply.”
- Get a medical cannabis program preservation plan approved. The plan must show how the processor will prioritize patients, manage customer traffic, prevent shortages and staff adequately.
- Pay $10 million or enter an approved installment plan by May 1, 2027.
- Join an impact licensee business accelerator plan for at least three years after verification. The plan is defined by the CCA’s Cannabis Impact Business Support Team (§ 4.1-604).
- Meet all other applicable licensing requirements, including a labor peace agreement attestation (§ 4.1-1001).
Consequences of not converting (set by law):
- A processor that has not applied and paid (or entered a plan) by May 1, 2027 may not exercise dual-use privileges or renew its permit (enactment 13).
- Effective June 1, 2027, no previously issued processor permit remains valid without dual-use verification (§ 4.1-1602 A).
In effect, staying medical-only is not an option under the enacted law.
The Board must verify dual-use privileges on or before May 1, 2027 (set by law, enactment 16). Adult-use sales start July 1, 2027.
Who may own and work there
- Owners: applicants’ material owners are fingerprinted and checked through the Central Criminal Records Exchange and the FBI, at the applicant’s cost (set by law, § 4.1-1602 G). Under § 4.1-1602.1 C, dual-use operators are also subject to the adult-use licensing rules. That brings in the § 4.1-810 7-year felony look-back for 10%+ owners.
- Staff: no one convicted of a felony in the last five years may work for or act as an agent of a processor or dispensing facility (set by law, § 4.1-1602 K). Drug screening policies are required (§ 4.1-1602 L). One pharmacist may supervise no more than six people doing pharmacy-technician work (§ 4.1-1602 M).
- Change of control: acquiring 25% or more needs prior Board approval (set by law, § 4.1-606 B 20).
Security, testing, tracking and labels
Dual-use operators follow the adult-use rules plus the medical ones (proposed in draft rules, Sept 2026):
- Security: monitored alarms with backup power, duress and panic alarms, full camera coverage with 30-day retention (3VAC10-40-140).
- Seed-to-sale: every plant tagged from seed, and adult-use and patient sales tracked separately (3VAC10-40-40; CCA update, Aug. 2026).
- Testing: every batch tested by a Virginia lab before sale (§ 4.1-1602 D; 3VAC10-60).
- Labels and packaging: child-resistant, opaque, with a QR code to the certificate of analysis (§ 4.1-1405); a decal on display (3VAC10-40-20 F).
- Patient supply: an adequate supply of CBD-dominant, low-THC products (§ 4.1-1602 P).
Taxes and federal status
Medical cannabis products are exempt from the 6% state marijuana tax. Adult-use sales are taxed at 6% (8% from July 1, 2029) plus a mandatory 1%-3.5% local marijuana tax and general sales tax (set by law, § 4.1-1004).
The DEA’s April 28, 2026 order placed in Schedule III only FDA-approved products and marijuana subject to a state medical license; other marijuana remains Schedule I (DEA final order). Our reading, not legal or tax advice: a dual-use operator may face different federal treatment for its medical and adult-use activity, including under IRC § 280E. Talk to a CPA and a Virginia-licensed attorney.
What it costs, and who can join
You cannot apply for dual-use privileges unless you already hold one of the five processor permits. The cost picture is the $10 million fee plus the draft permit fees above. The CCA does not publish operators’ build-out costs, and we found no verified figure for conversion capex.
Other ways to be involved:
- Invest in or partner with a processor. Any investment is subject to Board approval rules for ownership, financing and management agreements (§ 4.1-606 B 19). Remember the § 4.1-807 bar: an investor with 10%+ in a processor cannot hold interests in other licenses.
- Supply them: packaging, equipment, security, testing, staffing.
- Benefit from the accelerator as an impact licensee. Its terms are not yet published.
See every way into Virginia’s cannabis industry.
Concerns raised in public comment
At the September and October 2026 Board meetings, commenters raised concerns about the head start held by multistate medical operators. Hemp operators asked that their own conversion licenses be fast-tracked (CCA Board minutes, Sept. 9 and Oct. 21, 2026). The Board has not changed the statutory scheme, which only the General Assembly could do.
Why conversions could stall (watch list)
Other states’ denial data is not a good match here, because dual use is a verification of existing operators, not a competitive application. The enacted risks are specific:
- missing the May 1, 2027 payment or plan deadline;
- a preservation plan the CCA does not approve;
- no signed labor peace attestation;
- an ownership change made without prior Board approval (void under § 4.1-702 B).
What is still unknown
- The streamlined application and preservation-plan template (due by Feb. 1, 2027).
- Installment plan terms for the $10 million.
- Accelerator plan content: what processors must provide to impact licensees and how compliance is measured.
- Final permit fees (the September draft is not final; final rules are expected at the Dec. 16, 2026 Board meeting and effective in January 2027 per the CCA timeline).
- How dispensing sites count toward any regional allocation or market-concentration limits the Board adopts (§ 4.1-606 C 4, 5). The capacity study treats them as outside the 350 store cap.
Who can help
For processors and the businesses that work with them:
- Virginia-licensed cannabis and regulatory attorneys
- CPAs and tax counsel with § 280E and medical/adult-use allocation experience
- Pharmacy staffing, compliance and training providers
- Security integrators, packaging and labeling vendors, and seed-to-sale specialists
Browse the Virginia Cannabis Hub directory.
FAQ
Can a new company apply for dual-use privileges?
No. Only the five existing pharmaceutical processors and their dispensing facilities can be verified for dual use.
Do medical patients lose priority?
The law requires an approved preservation plan that prioritizes patients. The draft rules require at least 35 hours a week of patient access.
Do processors’ stores count toward the 350 retail license cap?
They are not retail store licenses. The CCA’s capacity study treats up to 30 processor sites as retail capacity outside the 350 cap.
What if a processor does not pay the $10 million?
After May 1, 2027 it cannot exercise dual-use privileges or renew its permit, and from June 1, 2027 its existing permit is no longer valid.
Can a processor also buy a stand-alone store or grow license?
No. Holders of a processor permit interest may hold no other marijuana establishment license except their own dispensing facility permits.
- HB 30, Chapter 1 (2026 Sp. Sess. I), Item 4-14: §§ 4.1-1602, 4.1-1602.1, 4.1-1603, 4.1-807, 4.1-1004; enactments 13, 16, 17
- CCA: Draft Proposed Adult-Use Regulations 2026 (Sept. 9, 2026), 3VAC10-20-30, -40; 3VAC10-30-90, -140; 3VAC10-40-25, -30
- CCA: Pharmaceutical processors
- CCA-commissioned Licensing and Cultivation Capacity Analysis (Oct. 2026)
- CCA: Retail Marijuana Market page (timeline)
- CCA update to the General Assembly transition group, Aug. 17, 2026
- CCA Board minutes, Sept. 9, 2026
- DEA final order, 91 FR (Apr. 28, 2026), FR Doc. 2026-08176
General information, not legal advice. Draft-rule figures can change in the final regulations.